Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, January 31, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
TAdvanced Thermal Cycler with Silver Block
Saturday, January 31, 2015
Highest speed and reproducibility for ultimate PCR performance.

Shimadzu Launches Nexera UC
Thursday, January 29, 2015
Nexera Unified Chromatography system showcases complete automation and combines automatic sample pre-treatment with chromatographic separation and analysis.

UK Biobank Selects Trinean’s DropSense96™
Wednesday, January 14, 2015
DropSense96™ droplet reader selected for DNA quantitation throughout its Genotyping project.

Affymetrix Expands Portfolio of Axiom Genotyping Arrays for Agrigenomics
Sunday, January 11, 2015
New offerings for porcine and equine studies.

Exiqon Launches Two New Research Use Only Kits
Friday, December 19, 2014
The miRSIGN™ miR-21 Oncogene assay and the miRSIGN™ Colon Cancer assay for PCR analysis of colon cancer samples.

Bio-Rad Introduces Bio-Plex Pro™ Human Inflammation Panels
Tuesday, December 16, 2014
Superior profiling of cancer, cardiovascular, and other disease biomarkers.

Sysquant® Awarded Two Contracts
Monday, December 01, 2014
Proteome Sciences provide an update on SysQuant ®, its phosphorylation assay that provides insight into normal cell function, disease state and response to drug treatments in patients.

Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments
Monday, November 03, 2014
The CFX Automation System II automates the operation of up to two CFX Real-Time PCR Detection Systems.

Bio-Rad’s New Automated Droplet Generator
Tuesday, October 28, 2014
New AutoDG™ instrument for Droplet Digital™ PCR saves time and improves data quality.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 727
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn